Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group
Jacob P. Laubach(Harvard University), Paul G. Richardson(Harvard University), A Mazumder(NYU Langone Health), Hermann Einsele(Universitätsklinikum Würzburg), Jesús F. San Miguel(Clinica Universidad de Navarra), Anuj Mahindra(University of California, San Francisco), Brian G.M. Durie(Cedars-Sinai Medical Center), Shaji Kumar(Mayo Clinic), Heinz Ludwig(Wilhelminen Hospital), Ingemar Turesson(Spanish Head & Neck Cancer Cooperative Group), Jian Hou(Shanghai Jiao Tong University), Kenneth C. Anderson(Dana-Farber Cancer Institute), Meletios Α. Dimopoulos(Korea University), Murielle Roussel(Centre Hospitalier Universitaire de Limoges), Robert Z. Orlowski(University of North Carolina at Chapel Hill), Evangelos Terpos(National and Kapodistrian University of Athens), Peter O’Gorman(University College Dublin), Artur Jurczyszyn(Jagiellonian University), Orhan Sezer(Charité - Universitätsmedizin Berlin), Xavier Leleu(Inserm), Elena Zamagni(Istituti di Ricovero e Cura a Carattere Scientifico), Tony Reiman(University of New Brunswick), Antonio Palumbo(University Hospital Brno), Matthew Streetly(King's College - North Carolina), Philip L. McCarthy(Roswell Park Comprehensive Cancer Center), S. Vincent Rajkumar(WinnMed), Hans Erik Johnsen(Herlev Hospital), Chor Sang Chim(Hong Kong Sanatorium and Hospital), Peter M. Voorhees(Levine Cancer Institute), U-H Mellqvist(University of Gothenburg), Junyu Lu(Guangxi Medical University), Philippe Moreau(Centre National de la Recherche Scientifique), Laurent Garderet(Inserm), D. Joshua(Royal Prince Alfred Hospital), Jan Westin(Spanish Head & Neck Cancer Cooperative Group), Goesta Gahrton(Karolinska University Hospital), L M Pilarski(University of Alberta), Sigurður Y. Kristinsson(Reykjavík University), W-J Chng(National University of Singapore), Jo Caers(University of Liège)
Cited by 256
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
|New England Journal of Medicine|2003|2.6k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Hematological findings and complications of <scp>COVID</scp>‐19
|American Journal of Hematology|2020|1.7k